Synergistic Effect of Additional Anlotinib and Immunotherapy As Second-Line or Later-Line Treatment in Pancreatic Cancer: A Retrospective Cohort Study
CANCER INNOVATION（2024）
Key words
anlotinib,efficacy,immunotherapy,independent risk factors,pancreatic ductal adenocarcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined